Hilton Capital Management’s CervoMed CRVO Stock Holding History

Hilton Capital Management’s Portfolio CRVO Stock Details CRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,315	Closed	-$140K	–	170
2025 Q3	$140K	Buy	+17,315	New	+$149K	0.01%	168

Other funds holding CRVO

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFG

Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PWM

Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return

Hilton Capital Management's CRVO Position: Q4 2025 in Review

Hilton Capital Management sold out of CervoMed (CRVO) in Q4 2025, closing a stake of 17,315 shares — an estimated $140K sold.

Hilton Capital Management first reported a position in CRVO in Q3 2025 and held it in 1 quarter. The position peaked at $140K in Q3 2025. 48 funds tracked by Wall St. Rank hold CRVO as of Q4 2025.

Hilton Capital Management reported no remaining CervoMed position as of Q4 2025 after selling out during the quarter.
Hilton Capital Management sold 17,315 CervoMed shares in Q4 2025, an estimated $140K.
Hilton Capital Management first reported a position in CervoMed in Q3 2025 and held it in 1 quarter.
Hilton Capital Management's CervoMed position peaked at $140K in Q3 2025.
48 funds tracked by Wall St. Rank held CervoMed as of Q4 2025.

Based on Hilton Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.